NovoCure Limited (NVCR) CEO Asaf Danziger on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha]
NovoCure Limited - Ordinary Shares (NVCR)
Last novocure limited - ordinary shares earnings: 4/30 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
novocure.com/investor-relations
Company Research
Source: Seeking Alpha
NovoCure Limited (NASDAQ:NVCRCompany ParticipantsAshley Cordova - Senior Vice President of Finance & Investor RelationsWilliam Doyle - Executive ChairmanAsaf Danziger - Chief Executive OfficerWilco Groenhuysen - Chief Financial OfficerPritesh Shah - Chief Commercial OfficerEly Benaim - Chief Medical OfficerConference Call ParticipantsVijay Kumar - Evercore ISIDifei Yang - Mizuho Securities Co., LtdEsther Rajavelu - Oppenheimer & Co. Inc.Cory Kasimov - JPMorgan Chase & Co.Gregory Fraser - SunTrust Robinson Humphrey, Inc.Jason Bednar - Piper Sandler CompaniesOperatorLadies and gentlemen, thank you for standing by and welcome to the Novocure First Quarter 2020 Earnings Conference Call. [Operator Instructions]I would now like to turn the conference to your speaker today, Ashley Cordova, Senior Vice President of Finance & Investor Relations. Please go ahead, ma'am.Good morning, everyone and thank you for joining us to review Novocure's first quarter 2020 performance. On behalf of the entir
Show less
Read more
Impact Snapshot
Event Time:
NVCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVCR alerts
High impacting NovoCure Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NVCR
News
- Novocure names Frank Leonard as CEO [Seeking Alpha]Seeking Alpha
- Novocure Appoints Company President Frank Leonard as Chief Executive OfficerBusiness Wire
- Novocure to Participate in 37th Annual Piper Sandler Healthcare ConferenceBusiness Wire
- Novocure to Participate in 2025 Jefferies Global Healthcare ConferenceBusiness Wire
- NovoCure (NASDAQ:NVCR) had its price target raised by analysts at HC Wainwright from $38.00 to $42.00. They now have a "buy" rating on the stock.MarketBeat
NVCR
Earnings
- 10/30/25 - Beat
NVCR
Sec Filings
- 12/1/25 - Form 8-K
- 11/13/25 - Form SCHEDULE
- 11/7/25 - Form SCHEDULE
- NVCR's page on the SEC website